agreed. Definitely required digging to come up with some numbers. They do say adding at least 40% to revenue by yr 4. And approx 50% margins. But would love to know what moq’s are.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
